Skip to content

Trulieve Cannabis

US · TRLV #2769 by market cap Listed 1970
8.68 -0.67 -7.17%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:55

Price chart

Pre-market 9.35 0.00%
After-hours 8.72 +0.46%
Overnight 9.10 -2.67%
13.008.068.682026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on TRLV?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +33.1% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 2.0% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B-
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 31.1x Better than 17%
Price / Sales 1.9x Better than 58%
Growth C+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) -1.0% Better than 21%
Net income CAGR (3Y) 18.3% Better than 71%
Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 60.2% Better than 75%
Operating margin 12.6% Better than 58%
Net margin -9.9% Better than 16%
Return on equity -9.6% Better than 20%
Return on invested capital -4.2% Better than 23%
Momentum B

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -21.8% Better than 28%
6-month return 15.7% Better than 78%
12-month return (ex latest month) 93.7% Better than 94%
Distance below 52-week high 34.6% Better than 35%
Financial Health B+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 4.4x Better than 83%
Debt to assets 20.9% Better than 55%
Interest coverage 2.4x Better than 40%
Analyst View A

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 107.4% Better than 85%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -20.37%
1M -19.56%
3M -15.32%
6M +8.64%
YTD -0.12%
1Y +81.48%
3Y +59.27%
5Y -70.18%

Key statistics

Price & volume

Prev close
9.35
Open
9.24
Day range
8.68 - 9.42
Avg price
8.90
Volume
1.71M
Turnover
15.24M
Amplitude
7.91%
52-week range
5.00 - 13.28

Valuation

P/E
-14.23
P/E (TTM)
-3.76
P/B
2.17
EPS
-0.61
Net profit
-117.75M
Net assets
771.57M

Share structure

Market cap
1.68B
Float cap
1.26B
Shares out
193.04M
Float shares
145.20M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 44% of range
5.00 13.28

34.6% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-6.04M net over the window

Short interest

Shares short
3.84M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Trulieve Cannabis (TRLV)?

Trulieve Cannabis last traded at 8.68. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Trulieve Cannabis's market cap?

About 1.68B.

What is the P/E ratio of Trulieve Cannabis?

The trailing twelve-month P/E is -3.76, below its own 5-year average of 0.66 — in the middle of its historical range (35.44% percentile). See the Valuation tab for the full history.

Does Trulieve Cannabis pay a dividend?

Trulieve Cannabis does not currently pay a regular dividend.

Is Trulieve Cannabis a buy according to analysts?

The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 18.00, which implies 107.4% upside from the current price. This is not investment advice.

What is Trulieve Cannabis's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Trulieve Cannabis a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:55:00 · For reference only, not investment advice and not tailored to your situation.

Trulieve Cannabis discussion 0 comments

Add a comment